NCT04825314

Brief Summary

Eighty percent of nosocomial UTI caused by indwelling urinary catheters and so known-as catheter-associated UTI. CAUTI leads to multiple local and systemic derangements such as suprapubic pain, dysuria, cystitis, pyelonephritis, septicemia, and even septic shock. This study will be conducted up on 100 patients (50 per each group) with long term catheterization to assess efficacy of noble metal alloy coated catheter in reducing CAUTI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 21, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2021

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

March 28, 2021

Last Update Submit

April 4, 2021

Conditions

Keywords

catheterUTIFoley catheterNobel Metal Alloy catheter

Outcome Measures

Primary Outcomes (1)

  • Urinary tract infection

    incidence of culture documented symotomatic urinary tract infection

    14 days

Secondary Outcomes (1)

  • Catheter tolerance

    14 days

Study Arms (2)

Bactiguard urethral catheter

ACTIVE COMPARATOR

Group A: Fifty Patients with urethral catheter using noble metal alloy coated catheter (Bactiguard AB, Stockholm ,Sweden).

Device: Urethral catheter

Silicone Foley urethral catheter

ACTIVE COMPARATOR

Group B: Fifty Patients with urethral catheter using silicone Foley catheter (Well Lead, Guangzhou, China).

Device: Urethral catheter

Interventions

All Patients will have urethral catheterization with either Noble Metal Alloy coated catheter or Silicon Foley catheter.

Bactiguard urethral catheterSilicone Foley urethral catheter

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patient under age of 80 years old who need prolonged urethral catheterization (more than 2 weeks) as a method of bladder drainage.

You may not qualify if:

  • Patients with current or recent symptomatic urinary tract infection.
  • Known hypersensitivity to latex, silver salts or hydrogel.
  • Patients with recent surgical intervention in the urinary tract.
  • Patients with anatomic or functional upper urinary tract issues (e.g reflux, stones, etc.)
  • Uncontrolled DM. Patients on corticosteroid treatment. Immunosuppressed patients. Patients received pelvic irradiation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria University Hospitals

Alexandria, 21646, Egypt

RECRUITING

Related Publications (1)

  • Aljohi AA, Hassan HE, Gupta RK. The efficacy of noble metal alloy urinary catheters in reducing catheter-associated urinary tract infection. Urol Ann. 2016 Oct-Dec;8(4):423-429. doi: 10.4103/0974-7796.192099.

    PMID: 28057985BACKGROUND

MeSH Terms

Conditions

Urinary Tract InfectionsCatheter-Related InfectionsInfections

Interventions

Urinary Catheters

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Central Study Contacts

Tamer A Abou Youssif, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 28, 2021

First Posted

April 1, 2021

Study Start

May 21, 2020

Primary Completion

May 21, 2021

Study Completion

June 21, 2021

Last Updated

April 8, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations